Journal article

Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma


Authors listSeliger, B; Handke, D; Schabel, E; Bukur, J; Lichtenfels, R; Dammann, R

Publication year2009

JournalJournal of Translational Medicine

Volume number7

ISSN1479-5876

eISSN1479-5876

DOI Linkhttps://doi.org/10.1186/1479-5876-7-90

PublisherBioMed Central


Abstract

Background: The ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) gene involved in the regulation of cellular ubiquitin levels plays an important role in different cellular processes including cell growth and differentiation. Aberrant expression of UCHL1 has been found in a number of human solid tumors including renal cell carcinoma (RCC). In RCC, UCHL1 overexpression is associated with tumor progression and an altered von Hippel Lindau gene expression. Methods: To determine the underlying mechanisms for the heterogeneous UCHL1 expression pattern in RCC the UCHL1 promoter DNA methylation status was determined in 17 RCC cell lines as well as in 32 RCC lesions and corresponding tumor adjacent kidney epithelium using combined bisulfite restriction analysis as well as bisulfite DNA sequencing. Results: UCHL1 expression was found in all 32 tumor adjacent kidney epithelium samples. However, the lack of or reduced UCHL1 mRNA and/or protein expression was detected in 13/32 RCC biopsies and 7/17 RCC cell lines and due to either a total or partial methylation of the UCHL1 promoter DNA. Upon 2'-deoxy-5-azacytidine treatment an induction of UCHL1 mRNA and protein expression was found in 9/17 RCC cell lines, which was linked to the demethylation degree of the UCHL1 promoter DNA. Conclusion: Promoter hypermethylation represents a mechanism for the silencing of the UCHL1 gene expression in RCC and supports the concept of an epigenetic control for the expression of UCHL1 during disease progression.




Citation Styles

Harvard Citation styleSeliger, B., Handke, D., Schabel, E., Bukur, J., Lichtenfels, R. and Dammann, R. (2009) Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma, Journal of Translational Medicine, 7, Article 90. https://doi.org/10.1186/1479-5876-7-90

APA Citation styleSeliger, B., Handke, D., Schabel, E., Bukur, J., Lichtenfels, R., & Dammann, R. (2009). Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma. Journal of Translational Medicine. 7, Article 90. https://doi.org/10.1186/1479-5876-7-90


Last updated on 2025-21-05 at 13:28